NRX Pharmaceuticals, Inc.

NRXP · Nasdaq · SIC 2834: Pharmaceutical Preparations
207
SEC Filings

Business Summary

Summary NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (NRx, the Company, we, us or our) is a clinical-stage bio-pharmaceutical company which develops and will distribute, through its wholly-owned operating subsidiary, NeuroRx, Inc., (NeuroRx), novel therapeutics for the treatment of central nervous system disorders including suicidal depression, chronic pain, post-traumatic stress disorder (PTSD) and schizophrenia. NRx is additionally the founder and majority owner of HOPE Therapeutics, Inc. (HOPE), ...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionNRXPdiscussed_in_filing Cybersecurity
topic_mentionNRXPdiscussed_in_filing Trusted Computing
topic_mentionNRXPdiscussed_in_filing Blockchain & Crypto
topic_mentionNRXPdiscussed_in_filing Regulation
topic_mentionNRXPdiscussed_in_filing Healthcare & Bio
topic_mentionNRXPdiscussed_in_filing Cybersecurity
topic_mentionNRXPdiscussed_in_filing Trusted Computing
topic_mentionNRXPdiscussed_in_filing Blockchain & Crypto
topic_mentionNRXPdiscussed_in_filing Regulation
topic_mentionNRXPdiscussed_in_filing Healthcare & Bio
topic_mentionNRXPdiscussed_in_filing Cybersecurity
topic_mentionNRXPdiscussed_in_filing Trusted Computing
topic_mentionNRXPdiscussed_in_filing Blockchain & Crypto
topic_mentionNRXPdiscussed_in_filing Regulation
topic_mentionNRXPdiscussed_in_filing Healthcare & Bio
topic_mentionNRXPdiscussed_in_filing Cybersecurity
topic_mentionNRXPdiscussed_in_filing Trusted Computing
topic_mentionNRXPdiscussed_in_filing Blockchain & Crypto
topic_mentionNRXPdiscussed_in_filing Regulation
topic_mentionNRXPdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-232025-12-310001437749-26-009418EDGAR96K words
2025-03-142024-12-310001437749-25-007743EDGAR
2024-03-292023-12-310001558370-24-004396EDGAR
2023-03-312022-12-310001558370-23-005292EDGAR
2022-03-312021-12-310001558370-22-004899EDGAR
2021-04-012020-12-310001654954-21-003783EDGAR
2020-03-302019-12-310001654954-20-003527EDGAR
2019-03-152018-12-310001654954-19-002833EDGAR
2018-03-232017-12-310001654954-18-003022EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001437749-25-035210EDGAR48K words
2025-08-182025-06-300001437749-25-027167EDGAR
2025-05-152025-03-310001437749-25-017252EDGAR
2024-11-142024-09-300001437749-24-035289EDGAR
2024-08-142024-06-300001437749-24-026847EDGAR
2024-05-142024-03-310001558370-24-008144EDGAR
2023-11-142023-09-300001558370-23-019008EDGAR
2023-08-142023-06-300001558370-23-014873EDGAR
2023-05-152023-03-310001558370-23-009950EDGAR
2022-11-142022-09-300001558370-22-017772EDGAR
2022-08-152022-06-300001558370-22-013673EDGAR
2022-05-162022-03-310001558370-22-008948EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001437749-26-009611EDGAR1K words
2026-02-170001437749-26-004246EDGAR
2026-02-170001437749-26-004245EDGAR
2026-02-020001437749-26-002682EDGAR
2026-01-160001437749-26-001455EDGAR
2025-12-290001437749-25-038835EDGAR
2025-11-260001437749-25-036452EDGAR
2025-10-230001437749-25-031637EDGAR
2025-09-260001437749-25-029907EDGAR
2025-09-120001437749-25-028949EDGAR

207 total filings indexed. 176 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001719406
TickerNRXP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 081e8d3270a002e1a7ab4e0671537c0d7bef3b5c592fcdf86cd41ef607ff9726
parent: 128f93269250094288b92c8829e186bac6a0ee9459e4de2e1606e12c8fed1259
content hash: e84b3efbc00ae01c72d98b153625fbc8922c8f568b665b881c55de050fe40097
signed: 2026-04-13T04:46:35.126Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf